Notice2025-12701

John Hanley, P.A.; Decision and Order

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
July 9, 2025

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 129 (Wednesday, July 9, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 129 (Wednesday, July 9, 2025)]
[Notices]
[Pages 30264-30265]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-12701]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


John Hanley, P.A.; Decision and Order

    On February 13, 2025, the Drug Enforcement Administration (DEA or 
Government) issued an Order to Show Cause (OSC) to John Hanley, P.A. of 
Santa Fe, New Mexico (Registrant). Request for Final Agency Action 
(RFAA), Exhibit (RFAAX) 1, at 1, 4. The OSC proposed the revocation of 
Registrant's Certificate of Registration No. MH4317702, alleging that 
Registrant's registration should be revoked because Registrant is 
``currently without authority to prescribe, administer, dispense, or 
otherwise handle controlled substances in New Mexico, the state in 
which [he is] registered with DEA.'' Id. at 2 (citing 21 U.S.C. 
824(a)(3) and 21 CFR 1301.37(b)).
    The OSC notified Registrant of his right to file a written request 
for hearing, and that if he failed to file such a request, he would be 
deemed to have waived her right to a hearing and be in default. Id. at 
2 (citing 21 CFR 1301.43). Here, Registrant did not request a hearing. 
RFAA, at 2.\1\ ``A default, unless excused, shall be deemed to 
constitute a waiver of the registrant's/applicant's right to a hearing 
and an admission of the factual allegations of the [OSC].'' 21 CFR 
1301.43(e).
---------------------------------------------------------------------------

    \1\ Based on the Government's submissions in its RFAA dated 
April 7, 2025, the Agency finds that service of the OSC on 
Registrant was adequate. The included declaration from a DEA 
Diversion Investigator (DI) indicates that on February 24, 2025, the 
DI, an additional DI, and other members of law enforcement attempted 
to personally serve Registrant with a copy of the OSC at 
Registrant's last known home address but were unsuccessful. RFAAX 2, 
at 1. The DI then emailed a copy of the OSC to Registrant's 
registered email address on February 26, 2025, and received a 
confirmation message from the Mail Delivery Subsystem that the OSC 
was relayed to that email address. In sum, the Agency finds that the 
DI's efforts to serve Registrant by email and other means were 
``reasonably calculated, under all the circumstances, to apprise 
[Registrant] of the pendency of the action.'' Jones v. Flowers, 547 
U.S. 220, 226 (2006) (quoting Mullane v. Central Hanover Bank & 
Trust Co., 339 U.S. 306, 314 (1950)); see also Mohammed S. Aljanaby, 
M.D., 82 FR 34552, 34552 (2017) (finding that service by email 
satisfies due process where the email is not returned as 
undeliverable and other methods have been unsuccessful). Therefore, 
due process notice requirements have been satisfied.
---------------------------------------------------------------------------

    Further, ``[i]n the event that a registrant . . . is deemed to be 
in default . . . DEA may then file a request for final agency action 
with the Administrator, along with a record to support its request. In 
such circumstances, the Administrator may enter a default final order 
pursuant to [21 CFR] 1316.67.'' Id. 1301.43(f)(1). Here, the Government 
has requested final agency action based on Registrant's default 
pursuant to 21 CFR 1301.43(c), (f), and 1301.46. RFAA, at 1; see also 
21 CFR 1316.67.

Findings of Fact

    The Agency finds that, in light of Registrant's default, the 
factual allegations in the OSC are admitted. According to the OSC, on 
or about February 27, 2024, the New Mexico Medical Board revoked 
Registrant's New Mexico physician assistant license. RFAAX 1, at 2. 
According to New Mexico online records, of which the Agency takes 
official notice, Registrant's New Mexico physician assistant license 
remains revoked.\2\ <a href="https://nmrldlpi.my.site.com/nmmb/s/searchlicense">https://nmrldlpi.my.site.com/nmmb/s/searchlicense</a> 
(last visited date of signature of this Order). Accordingly, the Agency 
finds that Registrant is not licensed to practice as a physician 
assistant in New Mexico, the state in which he is registered with 
DEA.\3\
---------------------------------------------------------------------------

    \2\ Under the Administrative Procedure Act, an agency ``may take 
official notice of facts at any stage in a proceeding--even in the 
final decision.'' United States Department of Justice, Attorney 
General's Manual on the Administrative Procedure Act 80 (1947) (Wm. 
W. Gaunt & Sons, Inc., Reprint 1979).
    \3\ Pursuant to 5 U.S.C. 556(e), ``[w]hen an agency decision 
rests on official notice of a material fact not appearing in the 
evidence in the record, a party is entitled, on timely request, to 
an opportunity to show the contrary.'' The material fact here is 
that Registrant, as of the date of this decision, is not licensed to 
practice as a physician assistant in New Mexico. Accordingly, 
Registrant may dispute the Agency's finding by filing a properly 
supported motion for reconsideration of findings of fact within 
fifteen calendar days of the date of this Order. Any such motion and 
response shall be filed and served by email to the other party and 
to the DEA Office of the Administrator, Drug Enforcement 
Administration at <a href="/cdn-cgi/l/email-protection#7b1f1e1a551a1f1f14551a0f0f1409151e02083b1f1e1a551c140d"><span class="__cf_email__" data-cfemail="2e4a4b4f004f4a4a41004f5a5a415c404b575d6e4a4b4f00494158">[email&#160;protected]</span></a>.
---------------------------------------------------------------------------

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under 21 U.S.C. 823 ``upon a 
finding that the registrant . . . has had his State license or 
registration suspended . . . [or] revoked . . . by competent State 
authority and is no longer authorized by State law to engage in the . . 
. dispensing of controlled substances.'' With respect to a 
practitioner, DEA has also long held that the possession of authority 
to dispense controlled substances under the laws of the state in which 
a practitioner engages in professional practice is a fundamental 
condition for obtaining and maintaining a practitioner's registration. 
Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (``The Attorney General 
can register a physician to dispense controlled substances `if the 
applicant is authorized to dispense . . . controlled substances under 
the laws of the State in which he practices.' . . . The very definition 
of a `practitioner' eligible to prescribe includes physicians 
`licensed, registered, or otherwise permitted, by the United States or 
the jurisdiction in which he practices' to dispense controlled 
substances. Sec.  802(21).''). The Agency has applied these principles 
consistently. See, e.g., James L. Hooper, M.D., 76 FR 71371, 71372 
(2011), pet. for rev. denied, 481 F. App'x 826 (4th Cir. 2012); 
Frederick Marsh Blanton, M.D., 43 FR 27616, 27617 (1978).\4\
---------------------------------------------------------------------------

    \4\ This rule derives from the text of two provisions of the 
CSA. First, Congress defined the term ``practitioner'' to mean ``a 
physician . . . or other person licensed, registered, or otherwise 
permitted, by . . . the jurisdiction in which he practices . . . , 
to distribute, dispense, . . . [or] administer . . . a controlled 
substance in the course of professional practice.'' 21 U.S.C. 
802(21). Second, in setting the requirements for obtaining a 
practitioner's registration, Congress directed that ``[t]he Attorney 
General shall register practitioners . . . if the applicant is 
authorized to dispense . . . controlled substances under the laws of 
the State in which he practices.'' 21 U.S.C. 823(g)(1). Because 
Congress has clearly mandated that a practitioner possess state 
authority in order to be deemed a practitioner under the CSA, DEA 
has held repeatedly that revocation of a practitioner's registration 
is the appropriate sanction whenever he is no longer authorized to 
dispense controlled substances under the laws of the state in which 
he practices See, e.g., James L. Hooper, M.D., 76 FR at 71371-72; 
Sheran Arden Yeates, M.D., 71 FR 39130, 39131 (2006); Dominick A. 
Ricci, M.D., 58 FR 51104, 51105 (1993); Bobby Watts, M.D., 53 FR 
11919, 11920 (1988); Frederick Marsh Blanton, M.D., 43 FR at 27617.
---------------------------------------------------------------------------

    According to New Mexico statute, ``dispense'' means ``to deliver a 
controlled substance to an ultimate user or research subject pursuant 
to the lawful order of a practitioner, including the administering, 
prescribing, packaging, labeling or compounding necessary to prepare 
the controlled substance for that delivery.'' N.M. Stat. Ann. Sec.  30-
31-2(H) (2024). Further, a ``practitioner'' means ``a physician . . . 
physician assistant, certified nurse practitioner . . . or other person 
licensed or certified to prescribe and

[[Page 30265]]

administer drugs that are subject to the [New Mexico] Controlled 
Substances Act.'' Id. Sec.  30-31-2(P). ``Physician assistants may 
prescribe, administer, dispense and distribute dangerous drugs; 
including Schedule II-V controlled substances, where there is an 
established physician assistant-patient relationship.'' N.M. Admin. 
Code 16.10.16.8(A) (2024). In this context, the physician assistant 
must be licensed by the New Mexico Medical Board to practice as such. 
Id. Sec. Sec.  16.10.16.1, 16.10.16.7(E).
    Here, the undisputed evidence in the record is that Registrant 
lacks authority to practice as a physician assistant in New Mexico 
because his New Mexico physician assistant license has been revoked. As 
discussed above, an individual must be a licensed practitioner to 
dispense a controlled substance in New Mexico. Thus, because Registrant 
lacks authority to practice as a physician assistant in New Mexico and, 
therefore, is not authorized to dispense controlled substances in New 
Mexico, Registrant is not eligible to maintain a DEA registration in 
New Mexico. Accordingly, the Agency will order that Registrant's DEA 
registration be revoked.

Order

    Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. 
MH4317702, issued to John Hanley, P.A. Further, pursuant to 28 CFR 
0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I 
hereby deny any pending applications of John Hanley, P.A., to renew or 
modify this registration, as well as any other pending application of 
John Hanley, P.A., for additional registration in New Mexico. This 
Order is effective August 8, 2025.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
July 2, 2025, by Acting Administrator Robert J. Murphy. That document 
with the original signature and date is maintained by DEA. For 
administrative purposes only, and in compliance with requirements of 
the Office of the Federal Register, the undersigned DEA Federal 
Register Liaison Officer has been authorized to sign and submit the 
document in electronic format for publication, as an official document 
of DEA. This administrative process in no way alters the legal effect 
of this document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2025-12701 Filed 7-8-25; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on July 9, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.